Dyer R - Search Results

1

Johnson LL, Dyer R, Hupe DJ. Johnson LL, et al. Among authors: dyer r. Curr Opin Chem Biol. 1998 Aug;2(4):466-71. doi: 10.1016/s1367-5931(98)80122-1. Curr Opin Chem Biol. 1998. PMID: 9736919 Review.

2

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors.

O'Brien PM, Ortwine DF, Pavlovsky AG, Picard JA, Sliskovic DR, Roth BD, Dyer RD, Johnson LL, Man CF, Hallak H. O'Brien PM, et al. Among authors: dyer rd. J Med Chem. 2000 Jan 27;43(2):156-66. doi: 10.1021/jm9903141. J Med Chem. 2000. PMID: 10649971

3

Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.

Wang Y, Johnson AR, Ye QZ, Dyer RD. Wang Y, et al. Among authors: dyer rd. J Biol Chem. 1999 Nov 12;274(46):33043-9. doi: 10.1074/jbc.274.46.33043. J Biol Chem. 1999. PMID: 10551873 Free article.

4

Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.

Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD. Johnson AR, et al. Among authors: dyer rd. J Biol Chem. 2007 Sep 21;282(38):27781-91. doi: 10.1074/jbc.M703286200. Epub 2007 Jul 10. J Biol Chem. 2007. PMID: 17623656 Free article.

5

Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK. Li JJ, et al. Among authors: dyer rd. J Med Chem. 2008 Feb 28;51(4):835-41. doi: 10.1021/jm701274v. Epub 2008 Feb 6. J Med Chem. 2008. PMID: 18251495

6

Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.

Lesch CA, Gilbertsen RB, Song Y, Dyer RD, Schrier D, Kraus ER, Sanchez B, Guglietta A. Lesch CA, et al. Among authors: dyer rd. J Pharmacol Exp Ther. 1998 Oct;287(1):301-6. J Pharmacol Exp Ther. 1998. PMID: 9765350

7

The role of arachidonic acid in the secretion of the amyloid precursor protein (APP).

Emmerling MR, Dudley DT, Dyer RD, Carroll RT, Doyle PD, Davis RE. Emmerling MR, et al. Among authors: dyer rd. Ann N Y Acad Sci. 1996 Jan 17;777:310-5. doi: 10.1111/j.1749-6632.1996.tb34438.x. Ann N Y Acad Sci. 1996. PMID: 8624105

8

2,6-di-tert-butylphenols: a new class of potent and selective PGHS-2 inhibitor.

Song Y, Connor DT, Sorenson RJ, Doubleday R, Sercel AD, Unangst PC, Gilbertsen RB, Chan K, Bornemeier DA, Dyer RD. Song Y, et al. Among authors: dyer rd. Inflamm Res. 1997 Aug;46 Suppl 2:S141-2. doi: 10.1007/s000110050145. Inflamm Res. 1997. PMID: 9297551 No abstract available.

9

Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors.

Unangst PC, Shrum GP, Connor DT, Dyer RD, Schrier DJ. Unangst PC, et al. Among authors: dyer rd. J Med Chem. 1992 Oct 2;35(20):3691-8. doi: 10.1021/jm00098a015. J Med Chem. 1992. PMID: 1433181

10

Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series.

Song Y, Connor DT, Sercel AD, Sorenson RJ, Doubleday R, Unangst PC, Roth BD, Beylin VG, Gilbertsen RB, Chan K, Schrier DJ, Guglietta A, Bornemeier DA, Dyer RD. Song Y, et al. Among authors: dyer rd. J Med Chem. 1999 Apr 8;42(7):1161-9. doi: 10.1021/jm980570y. J Med Chem. 1999. PMID: 10197960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

959 results

Search Page